epidermal-growth-factor and Lymphoma--Non-Hodgkin

epidermal-growth-factor has been researched along with Lymphoma--Non-Hodgkin* in 1 studies

Other Studies

1 other study(ies) available for epidermal-growth-factor and Lymphoma--Non-Hodgkin

Article	Year
Unraveling the complexities of targeted therapy treatment in cancer care. ONS news, 2004, Volume: 19, Issue:9 Suppl This program discussed the rationale for treatment choices in non-Hodgkin lymphoma and HER-2 positive breast cancer. The mechanisms and management of infusion, cytokine-mediated, and allergic reactions related to monoclonal antibody (MOAB) therapy were covered, as well as a summary of the mechanisms of action and toxicities of MOAB therapy in breast cancer. Topics: Antibodies, Monoclonal; Breast Neoplasms; Drug Delivery Systems; Epidermal Growth Factor; Genes, erbB-2; Humans; Lymphoma, Non-Hodgkin; Oncology Nursing; Patient Education as Topic; Vascular Endothelial Growth Factor A	2004

Article

Year

Unraveling the complexities of targeted therapy treatment in cancer care.

ONS news, 2004, Volume: 19, Issue:9 Suppl

This program discussed the rationale for treatment choices in non-Hodgkin lymphoma and HER-2 positive breast cancer. The mechanisms and management of infusion, cytokine-mediated, and allergic reactions related to monoclonal antibody (MOAB) therapy were covered, as well as a summary of the mechanisms of action and toxicities of MOAB therapy in breast cancer.

Topics: Antibodies, Monoclonal; Breast Neoplasms; Drug Delivery Systems; Epidermal Growth Factor; Genes, erbB-2; Humans; Lymphoma, Non-Hodgkin; Oncology Nursing; Patient Education as Topic; Vascular Endothelial Growth Factor A

2004